Justice N V Anjaria yesterday upheld the government's contention that prohibition of consumption of poppy capsules should not be seen as violation of the fundamental right to live.
The notification dated October 5, 2015, prohibits issuance of licence to procure poppy capsules on health grounds. The prohibition came into effect from March 31, 2016.
The petitioner contended that this violated the fundamental rights including the right to live under Article 21 of the Constitution, as those addicted to poppy capsules may face severe withdrawal complications if denied access to the narcotic.
But Gujarat government said it had the power to prohibit consumption of a substance which is already a prohibited substance under Narcotic Drugs and Psychotropic Substances Act, 1985.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
